Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Consolidated Water Declares Fourth Quarter Cash Dividend
-
PolarityBio to Share Regenerative Wound Healing Expertise at SAWC Fall 2025
-
Elder Margaret Head-Steppan Appointed as Elder of Visionary and Osawi, Establishing First-of-Its-Kind Relationship in Canadian Exploration
-
IBN Initiates Coverage of GlobalTech Corp.
-
Sustainable Innovation & Health Dividend Fund Normal Course Issuer Bid
-
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
-
CorMedix to Participate in Upcoming Investor Conferences
-
FDCTech, Inc. Announces the Launch of Copy Trading Platform by Subsidiary Alchemy Markets
-
SEALSQ Enhances INeS PKI Platform with Code Signing Capability to Secure Firmware Integrity in Alignment with RED and CRA Regulations
-
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
-
Early Expiration Price Condition for Warrants Satisfied Alternate Expiration Date Elected
-
Snail Games Advances Multi-Label Publishing Strategy with New Milestones, Events, and Upcoming Releases
-
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
-
HeartCore Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
-
Zeo Energy Corp. to Present at the 2025 Gateway Conference on September 4th
-
FAST TRACK GROUP Issues Letter to Shareholders to Discuss Recent Business Developments and Future Growth Strategies
-
Mezrah Consulting Launches Their MSO Deferral Plan™ Strategy and Partner Platform
-
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
-
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Pioneering Innovative Mining Approach, Demonstrating Next-Gen Processing Capabilities
-
Apollo to Present at the Barclays Global Financial Services Conference
-
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
-
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
-
Oklahoma State University Becomes First Official Sportsmo Partner, Launching in Time for Season Opener Today
-
Alarum Technologies Announces Second Quarter 2025 Results
-
GlobalFoundries Announces Production Release of 130CBIC SiGe Platform for High-Performance Smart Mobile, Communication and Industrial Applications
-
NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
-
Form 8.3 - Warehouse REIT Plc
-
CryptoVirally Expands Web3 Marketing Services, Unifying PR, KOLs, and Community Growth Into One Full-Funnel Program
-
Leading Silicon Coating Manufacturer to Sell Fully Equipped Pressure-Sensitive Release Liner Manufacturing Plant on AllSurplus Marketplace
-
Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry
-
GlobalFoundries Announces Availability of 22FDX+ RRAM Technology for Wireless Connectivity and AI Applications
-
Scottish Medtech Seluna Launches Pediatric Sleep Trial Ahead of U.S. Entry
-
Form 8.3 - Life Science REIT Plc
-
Form 8.3 - Empiric Student Property Plc
-
VEON and Kyivstar to Host Investor Meeting on August 28, 2025
-
Form 8.3 - Apax Global Alpha Limited
-
IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
-
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
-
$3.5 Million Nashville Derby and $2 Million Ladies Turf Sprint Headline One of the Richest Days in U.S. Racing at Kentucky Downs
-
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
-
EXL to participate in Citi Global TMT Conference in New York
-
Biptap Expands to Africa with Central African Republic Deal
-
Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors
-
Marker Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
-
CF Energy Announces Financial Results For the Three-month and Six-month periods ended June 30, 2025
-
Cultivarium Introduces POSSUM Toolkit For Rapid Plasmid Identification at Scale
-
Kestra Medical Technologies, Ltd. to Report First Quarter Fiscal 2026 Financial Results
-
Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences
-
Enphase Energy Announces Availability of Software to Expand IQ7 Solar Systems with IQ8 Microinverters in More Global Markets
